SHE:002880 - Shenzhen Weiguang Biological Products Co Ltd

Shenzhen Weiguang Biological P
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q2	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	197.14M 42.2%	280.97M 42.5%	290.68M 3.5%	137.78M -52.6%	94.06M -31.7%	179.59M 90.9%	256.5M 42.8%	208.52M -18.7%	248.65M 19.2%	278.27M 11.9%	313.07M 12.5%	226.3M -27.7%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	117.8M 43.6%	165.77M 40.7%	170.9M 3.1%	78.62M -54.0%	49.9M -36.5%	114.99M 130.4%	183.51M 59.6%	121.48M -33.8%	142.97M 17.7%	155.46M 8.7%	195.35M 25.7%	128.36M -34.3%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	79.35M 40.2%	115.2M 45.2%	119.77M 4.0%	59.16M -50.6%	44.16M -25.4%	64.6M 46.3%	72.98M 13.0%	87.04M 19.3%	105.68M 21.4%	122.8M 16.2%	117.72M -4.1%	97.94M -16.8%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	147.01M 33.5%	205.15M 39.5%	208.09M 1.4%	108.09M -48.1%	71.13M -34.2%	150.29M 111.3%	221.25M 47.2%	152.37M -31.1%	185M 21.4%	214.08M 15.7%	247.91M 15.8%	165.98M -33.0%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	29.21M 4.0%	39.37M 34.8%	37.19M -5.6%	29.47M -20.8%	21.23M -28.0%	35.31M 66.3%	37.74M 6.9%	30.89M -18.1%	42.03M 36.1%	58.62M 39.5%	52.56M -10.3%	37.62M -28.4%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	50.13M 75.9%	75.82M 51.2%	82.59M 8.9%	29.69M -64.0%	22.93M -22.8%	29.3M 27.8%	35.25M 20.3%	56.15M 59.3%	63.65M 13.4%	64.18M 0.8%	65.16M 1.5%	60.32M -7.4%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	69.7M -	-	-	-	46.83M -	-	-	-	100.89M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.97M 59.2%	67.71M 57.6%	67.76M 0.1%	25.33M -62.6%	21.55M -14.9%	25.88M 20.1%	44.75M 72.9%	45.74M 2.2%	55.29M 20.9%	50.22M -9.2%	67.41M 34.2%	46.83M -30.5%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.189 13.7%	0.298 57.5%	0.299 0.1%	0.112 -62.6%	0.095 -15.0%	0.114 20.2%	0.197 72.8%	0.202 2.2%	0.244 20.8%	0.221 -9.2%	0.297 34.3%	0.206 -30.5%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.189 13.7%	0.298 57.5%	0.299 0.1%	0.112 -62.6%	0.095 -15.0%	0.114 20.2%	0.197 72.8%	0.202 2.2%	0.244 20.8%	0.221 -9.2%	0.297 34.3%	0.206 -30.5%